Document is current
Any future updates will be listed below
-
Authors
Schellong, Paul https://orcid.org/0000-0002-5382-0083
Joean, Oana
Pletz, Mathias W.
Hagel, Stefan
Weis, Sebastian
-
Funding
Funding for this research was provided by:
Universitätsklinikum Jena
- License Information
-
More Information
Article History
Accepted: 28 November 2024
First Online: 25 December 2024
Declarations
:
: Open Access funding enabled and organized by Projekt DEAL.
: SW has received honoraria for presentations from InfectoPharm. SH has received honoraria for presentations from InfectoPharm, Pfizer, MSD, Philips, Advanz, Beckman Coulter, Thermofisher, Shionogi, and Tillots. MP has received honoraria for presentations from MSD, Novartis, and Pfizer and honoraria for presentations and an educational podcast and a research grant from InfectoPharm. All other authors declare that they have no conflicts of interest.
: PS, MP, SH, SW: concept and planning of the review. PS: first draft of Sections , , , , and the tables; integration of first drafts of the other sections into the full manuscript. OJ: first draft of Sections and . SH: first draft of Section . SW: first draft of Sections and . All authors: critical revision and approval of the final submitted version of the manuscript
: Not applicable.
: Not applicable.
: Not applicable.
